Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.

Research activity is centered on subcutaneous immunotherapy for allergic rhinitis and allergic rhinoconjunctivitis, including patients with associated controlled allergic asthma. The sponsor focuses on treatment approaches targeting sensitization to specific allergens.

• Dermatophagoides pteronyssinus allergen components
• Der p 1, Der p 2, and Der p 23
• Cup a 1 immunotherapy

These studies reflect a strong interest in allergen-specific treatment for respiratory allergy conditions driven by defined sensitization profiles.